Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Aceso Life Science Group Limited ( (HK:0474) ) has provided an update.
Hong Kong’s Securities and Futures Commission has warned of a high concentration of shareholding in Aceso Life Science Group Limited, with three substantial shareholders and 20 other shareholders plus related parties together controlling more than 90% of the company’s issued shares, leaving less than 10% in the hands of the broader market. The regulator cautioned that this tight free float, combined with a 521% surge in Aceso’s share price between September 2025 and January 2026, means the stock is vulnerable to substantial price swings even on relatively small trading volumes, and urged investors to exercise extreme caution when dealing in the shares.
The most recent analyst rating on (HK:0474) stock is a Sell with a HK$0.12 price target. To see the full list of analyst forecasts on Aceso Life Science Group Limited stock, see the HK:0474 Stock Forecast page.
More about Aceso Life Science Group Limited
Average Trading Volume: 11,135,445
Technical Sentiment Signal: Buy
Current Market Cap: HK$885.8M
For detailed information about 0474 stock, go to TipRanks’ Stock Analysis page.